Lnhc Drug Patent Portfolio
Lnhc owns 2 orange book drugs protected by 17 US patents Given below is the list of Lnhc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10322081 | Topical antiviral compositions and methods of using the same | 10 Jul, 2035 | Active |
| US10736839 | Topical antiviral compositions, delivery systems, and methods of using the same | 10 Jul, 2035 | Active |
| US11040006 | Topical antiviral compositions, delivery systems, and methods of using the same | 10 Jul, 2035 | Active |
| US11723858 | Topical antiviral compositions, delivery systems, and methods of using the same | 10 Jul, 2035 | Active |
| US10258564 | Topical compositions and methods of using the same | 22 Nov, 2034 | Active |
| US11285098 | Topical compositions and methods of using the same | 28 Feb, 2034 | Active |
| US9855211 | Topical compositions and methods of using the same | 27 Feb, 2034 | Active |
| US10265334 | Anhydrous compositions | 03 Jul, 2032 | Active |
| US9289442 | Topical compositions | 03 Jul, 2032 | Active |
| US9526738 | Topical gels and methods of using the same | 03 Sep, 2031 | Active |
| US10376538 | Topical gels and methods of using the same | 20 Aug, 2030 | Active |
| US9737561 | Topical gels and methods of using the same | 20 Aug, 2030 | Active |
| US8592434 | Mucoadhesive buccal tablets for the treatment of orofacial herpes | 16 Jun, 2030 | Active |
| US8747896 | Mucosal bioadhesive slow release carrier for delivering active principles | 03 Jun, 2027 | Active |
| US8791127 | Mucosal bioadhesive slow release carrier for delivering active principles | 23 Mar, 2027 | Active |
| US8282967 | Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications | 30 May, 2026 | Active |
| US8956658 | Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications | 30 May, 2026 | Active |
Latest Legal Activities on Lnhc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Lnhc.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Yr, Small Entity | 27 Jun, 2024 | US9526738 |
| Payment of Maintenance Fee, 12th Yr, Small Entity | 22 Mar, 2024 | US8282967 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 05 Mar, 2024 | US9855211 |
|
Email Notification
Critical
| 05 Mar, 2024 | US9855211 |
| Initial letter Re: PTE Application to regulating agency | 04 Mar, 2024 | US9855211 |
| Patent Term Extension Application under 35 USC 156 Filed | 01 Mar, 2024 | US9855211 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 12 Feb, 2024 | US10736839 |
|
Electronic Review
Critical
| 15 Aug, 2023 | US11723858 |
|
Recordation of Patent Grant Mailed
Critical
| 15 Aug, 2023 | US11723858 |
| Mail Patent eGrant Notification | 15 Aug, 2023 | US11723858 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 15 Aug, 2023 | US11723858 |
| Recordation of Patent eGrant | 15 Aug, 2023 | US11723858 |
|
Email Notification
Critical
| 15 Aug, 2023 | US11723858 |
| Patent eGrant Notification | 15 Aug, 2023 | US11723858 |
|
Email Notification
Critical
| 27 Jul, 2023 | US11723858 |
Lnhc's Family Patents
Lnhc drugs have patent protection in a total of 30 countries. It's US patent count contributes only to 15.4% of its total global patent coverage. 3 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Lnhc Drug List
Given below is the complete list of Lnhc's drugs and the patents protecting them.
1. Sitavig
Sitavig is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8592434 | Mucoadhesive buccal tablets for the treatment of orofacial herpes |
16 Jun, 2030
(5 years from now)
| Active |
| US8747896 | Mucosal bioadhesive slow release carrier for delivering active principles |
03 Jun, 2027
(2 years from now)
| Active |
| US8791127 | Mucosal bioadhesive slow release carrier for delivering active principles |
23 Mar, 2027
(2 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Sitavig's drug page
2. Zelsuvmi
Zelsuvmi is protected by 14 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10322081 | Topical antiviral compositions and methods of using the same |
10 Jul, 2035
(10 years from now)
| Active |
| US10736839 | Topical antiviral compositions, delivery systems, and methods of using the same |
10 Jul, 2035
(10 years from now)
| Active |
| US11040006 | Topical antiviral compositions, delivery systems, and methods of using the same |
10 Jul, 2035
(10 years from now)
| Active |
| US11723858 | Topical antiviral compositions, delivery systems, and methods of using the same |
10 Jul, 2035
(10 years from now)
| Active |
| US10258564 | Topical compositions and methods of using the same |
22 Nov, 2034
(9 years from now)
| Active |
| US11285098 | Topical compositions and methods of using the same |
28 Feb, 2034
(9 years from now)
| Active |
| US9855211 | Topical compositions and methods of using the same |
27 Feb, 2034
(9 years from now)
| Active |
| US10265334 | Anhydrous compositions |
03 Jul, 2032
(7 years from now)
| Active |
| US9289442 | Topical compositions |
03 Jul, 2032
(7 years from now)
| Active |
| US9526738 | Topical gels and methods of using the same |
03 Sep, 2031
(6 years from now)
| Active |
| US10376538 | Topical gels and methods of using the same |
20 Aug, 2030
(5 years from now)
| Active |
| US9737561 | Topical gels and methods of using the same |
20 Aug, 2030
(5 years from now)
| Active |
| US8282967 | Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
30 May, 2026
(1 year, 5 months from now)
| Active |
| US8956658 | Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
30 May, 2026
(1 year, 5 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zelsuvmi's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List